In SLE patients, the mRNA levels of CD62L were comparable in effector and CD4+CD25low/-GITR+ cells, suggesting that these cells were not activated effector cells and possibly were Treg cells maintaining regulatory activity. The gene discussed is SELL; the disease is systemic lupus erythematosus.